Rocklatan eye drop study for early glaucoma
Part of Eyes & vision clinical trials.
This study tests a combination eye drop called Rocklatan to see how it affects blood flow in the back of the eye (retina) in people with early open-angle glaucoma. You'll use the drops and have special eye scans to measure blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have open-angle glaucoma in both eyes.
- Your eye pressure must be at least 17 mmHg while using latanoprost drops (a common glaucoma treatment).
- You need to have early glaucoma damage, shown by visual field tests and thicker-than-average nerve fiber layer (the nerve layer in the back of your eye) in both eyes.
- Your vision must be fairly good — better than 20/30 (with glasses or contacts if you use them).
- You can't have other eye diseases that could affect the results, like significant cataracts, age-related macular degeneration, diabetic retinopathy, or optic nerve damage from other causes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
This study looks at how the optic nerve (the part of your eye that sends images to your brain) strains or bends in people who do not have glaucoma. It uses advanced eye imaging and home pressure checks to understand the nerve's health.
This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.
This study compares two versions of latanoprost eye drops—one that contains a preservative and one that is preservative-free. It aims to see how each version affects the eye’s “goblet cells,” which help keep the eye surface healthy.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.